Skip to content

Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS

Effects of Fospropofol Disodium-Based Total Intravenous Anesthesia and Intravenous-Inhalation Combined Anesthesia on Surgical Field Quality in Adult Endoscopic Sinus Surgery: A Randomized Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07788157
Enrollment
144
Registered
2026-08-26
Start date
2026-07-12
Completion date
2026-12-31
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fospropofol Disodium

Brief summary

Endoscopic sinus surgery (ESS) is a primary surgical approach for treating chronic rhinosinusitis, nasal polyps, and other conditions that are unresponsive to conservative therapy. A clear surgical field is a critical prerequisite for ensuring precision, efficiency, and the avoidance of injury to vital structures such as the orbit and the skull base. Currently, the anesthetic regimens commonly used for ESS include total intravenous anesthesia (TIVA), inhalational anesthesia (IA), and intravenous-inhalational combined anesthesia (IVIH). However, there remains controversy regarding the comparative effects of these three modalities on surgical field quality. IVIH, as an anesthetic strategy that integrates the advantages of both intravenous and inhalational agents, is widely employed in clinical practice. In the context of ESS, it may reduce the dose of individual agents through combination therapy, thereby minimizing dose-related adverse effects. Some studies have shown that propofol-based TIVA provides better surgical field conditions than inhalational anesthetics (e.g., desflurane, sevoflurane), but does not significantly reduce total blood loss or shorten operative time. Nevertheless, propofol is associated with drawbacks such as injection pain and propofol infusion syndrome. Fospropofol disodium, a water-soluble prodrug of propofol, offers a significant advantage in reducing injection pain and provides more stable hemodynamic profiles.

Interventions

Fospropofol disodium induction and fospropofol disodium maintenance with or without sevoflurane.

DRUGPropofol

Propofol induction and propofol maintenance with or without sevoflurane.

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18-65 years * ASA physical status I-II * BMI 18-35 kg/m² * diagnosed with chronic rhinosinusitis (with or without nasal polyps) and scheduled for elective endoscopic sinus surgery * provided written informed consent

Exclusion criteria

* uncontrolled hypertension or asthma * use of medications that may affect coagulation function (e.g., NSAIDs) within 1 week prior to surgery * pre-existing coagulation abnormalities * history of bleeding disorders * history of drug allergy (to propofol, fospropofol disodium, or sevoflurane) * other comorbidities, such as uncorrected congenital heart disease, neuromuscular disorders, or hepatic/renal dysfunction * recent participation in other clinical studies

Design outcomes

Primary

MeasureTime frameDescription
The score of the Wormald scaleFrom the start of surgery to the end of surgeryThe Wormald scales was used to assess the quality of the surgical field, 0-10 points, with higher scores indicating worse visual field.
The score of the Boezaart scaleFrom the start of surgery to the end of surgeryThe Boezaart scales was used to assess the quality of the surgical field, 0-5 points, with higher scores indicating worse visual field.

Secondary

MeasureTime frameDescription
Total blood lossPerioperativeTotal fluid volume in the suction canister at the end of surgery minus the total irrigation volume during surgery
The rate of bleedingPerioperativeTotal blood loss divided by surgical duration
Induction timePerioperativeFrom the start of anesthesia to loss of consciousness
Extubation timePerioperativeFrom the end of anesthesia to extubation
Emergence timePerioperativeFrom the end of anesthesia to recovery of consciousness
PACU length of stayPerioperativeFrom admission to the PACU until meeting discharge criteria
Emergence agitationPerioperativeEmergence agitation was assessed using the Richmond Agitation-Sedation Scale (RASS), the range is between -5 and +4, higher scores mean a worse outcome in terms of sedation level (too agitated) and a worse outcome in terms of over-sedation (too deeply sedated).
Postoperative pain scorePerioperativePostoperative pain score was assessed using the Visual Analogue Scale (VAS), the range is between 0-10, higher scores mean a worse outcome (indicating more severe pain).
Postoperative nausea and vomiting (PONV)PerioperativeUse a questionnaire to assess the incidence of postoperative nausea and vomiting.

Countries

China

Contacts

CONTACTAijun Xu, Dr
ajxu@tjh.tjmu.edu.cn027-83663423
STUDY_DIRECTORAihua Du, Dr

Tongji Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026